Personal Health Monitoring Becomes Outcome-Driven

TytoCare, a telehealth platform and remote care device maker, has added another $50 million to its Series D funding round, bringing the oversubscribed round to a total of $100 million.

The Israeli startup raised the first $50 million in April 2020 in a round led by Insight Partners, which led this extension as well. New investors Tiger Global Management and Qumra Capital joined this time around, as well as investors from previous rounds, including Qualcomm Ventures, Olive Tree Ventures, and Shenzhen Capital Group Company. Read more…

FundGuard, an AI-powered software-as-a-service investment management platform, today announced that it closed a $12 million funding round. The investment will spur product development to support existing partnerships, FundGuard says, in addition to helping to meet demand from alternative funds and insurers.

AI is increasingly being used to manage assets toward the goal of maximizing returns on investments. For example, trading algorithms leverage AI to devise novel signals and execute trades with lower overall transaction costs. AI can also bolster risk modeling and forecasting by generating insights from previously untapped data sources. Read more

LawGeex, a startup that automates the contract review process, has patented its artificial intelligence technology — a milestone that signals growing comfort with machine learning in law and could accelerate growth for the business.

The AI analyzes documents based on the contract’s context with “the mind of a human lawyer,” according to Noory Bechor, the company’s co-founder and CEO. This contextual approach takes into account surrounding factors like company policies, the document type, and whether the client is the buyer or seller. Read more

Rhino Health, a startup leveraging federated learning to connect hospitals and AI developers, today emerged from stealth with $5 million. The company says it will use the funds to further develop its platform, which provides access to distributed datasets from a diverse group of patients.

Read more

The Prescribed Wearable Device is Now indicated for Patients 12 Years Old and Above

NETANYA, Israel and MONTCLAIR, N.J., Jan. 25, 2021 /PRNewswire/ — Theranica, a prescribed digital therapeutics (PDT) company developing advanced electroceuticals for migraine and other pain conditions, today announced that its Nerivio® therapeutic device has received the Food and Drug Administration clearance to market for an expanded indication for acute treatment of episodic or chronic migraine in people 12 years and older. The use of the device in the treatment of adolescents is supported by a study recently published in Headache. Read more…

We believe that 2020 represents an unprecedented inflection point in digital health, and aim to lay out the trends that we believe will define the coming decade, as well as the implications of these trends for our investment strategy.

News, insights and theses from the team at LionBird

We are looking for solutions that go beyond “blockchain for healthcare” — we want to see how these solutions are truly providing safe, trusted, and transparent sharing of medical data, and particularly how those solutions respect patient rights and patient privacy.

Combining more granular monitoring of physiology with home diagnostics means that healthcare may finally have the data that can drive meaningful analytics and interventions to prevent illness, the ultimate goal of any population health-centric system.